Literature DB >> 30332620

Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

Silvia Grazioli1, Maddalena Mauri2, Alessandro Crippa1, Eleonora Maggioni3, Massimo Molteni1, Paolo Brambilla4, Maria Nobile1.   

Abstract

BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD.
METHODS: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine.
RESULTS: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found. LIMITATIONS: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients' medication status and washout period, explored cerebral regions, and neuropsychological tasks.
CONCLUSIONS: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADHD; Biomarker; Pharmachological-treatment; Rehabilitation; fNIRS

Mesh:

Substances:

Year:  2018        PMID: 30332620     DOI: 10.1016/j.jad.2018.10.100

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  What Has Been Learned from Using EEG Methods in Research of ADHD?

Authors:  Gráinne McLoughlin; Máté Gyurkovics; Ümit Aydin
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 2.  Assessment of age-related decline of neurovascular coupling responses by functional near-infrared spectroscopy (fNIRS) in humans.

Authors:  Tamas Csipo; Peter Mukli; Agnes Lipecz; Stefano Tarantini; Dhay Bahadli; Osamah Abdulhussein; Cameron Owens; Tamas Kiss; Priya Balasubramanian; Ádám Nyúl-Tóth; Rachel A Hand; Valeriya Yabluchanska; Farzaneh A Sorond; Anna Csiszar; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2019-11-02       Impact factor: 7.713

3.  Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients.

Authors:  Atsunori Sugimoto; Yutaro Suzuki; Kiyohiro Yoshinaga; Naoki Orime; Taketsugu Hayashi; Jun Egawa; Shin Ono; Takuro Sugai; Toshiyuki Someya
Journal:  Front Hum Neurosci       Date:  2021-11-26       Impact factor: 3.169

4.  Transcutaneous electrical acupoint stimulation for children with attention-deficit/hyperactivity disorder: a randomized clinical trial.

Authors:  Lixia Zhuo; Xiaoyan Zhao; Yifang Zhai; Boqiang Zhao; Lin Tian; Yannan Zhang; Xiaodan Wang; Tingyu Zhang; Xinyi Gan; Cheng Yang; Weigang Wang; Wei Gao; Qiang Wang; Luis Augusto Rohde; Jie Zhang; Yan Li
Journal:  Transl Psychiatry       Date:  2022-04-21       Impact factor: 7.989

5.  Association Between Fatty Acids Profile and Cerebral Blood Flow: An Exploratory fNIRS Study on Children with and without ADHD.

Authors:  Silvia Grazioli; Alessandro Crippa; Maddalena Mauri; Caterina Piazza; Andrea Bacchetta; Antonio Salandi; Sara Trabattoni; Carlo Agostoni; Massimo Molteni; Maria Nobile
Journal:  Nutrients       Date:  2019-10-10       Impact factor: 5.717

6.  Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study.

Authors:  Jie Li; Wen-Jie Yan; Yan Wu; Xin-Xin Tian; Yi-Wen Zhang
Journal:  Front Behav Neurosci       Date:  2022-01-05       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.